ES2140075T3 - Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen. - Google Patents

Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.

Info

Publication number
ES2140075T3
ES2140075T3 ES96909193T ES96909193T ES2140075T3 ES 2140075 T3 ES2140075 T3 ES 2140075T3 ES 96909193 T ES96909193 T ES 96909193T ES 96909193 T ES96909193 T ES 96909193T ES 2140075 T3 ES2140075 T3 ES 2140075T3
Authority
ES
Spain
Prior art keywords
alcylloyl
radical
sub
general formula
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96909193T
Other languages
English (en)
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9503545A external-priority patent/FR2732340B1/fr
Priority claimed from FR9515381A external-priority patent/FR2742754B1/fr
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2140075T3 publication Critical patent/ES2140075T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NUEVOS TAXOIDES DE FORMULA GENERAL (I), SU PREPARACION Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. EN LA FORMULA GENERAL (I), Z REPRESENTA UN ATOMO DE HIDROGENO O UN RADICAL DE FORMULA GENERAL (II) EN LA QUE R{SUB,1} REPRESENTA UN RADICAL BENZOILO, EVENTUALMENTE SUSTITUIDO, O UN RADICAL TENOILO O FUROILO, UN RADICAL R{SUB,2} RESENTA UN RADICAL ALCOILO, ALCENILO, ALCINILO, CICLOALCOILO, CICLOALCENILO, BICICLOALCOILO, FENILO, EVENTUALMENTE SUSTITUIDO, O HETEROCICLILO, R{SUB,3} REPRESENTA UN RADICAL ALCOILO, ALCENILO, ALCINILO, CICLOALCOILO, FENILO, NAFTILO O HETEROCICLICO AROMATICO, R{SUB,4} REPRESENTA UN RADICAL ALCOXI, ALCENILOXI, ALCINILOXI, EVENTUALMENTE SUSTITUIDO, O UN RADICAL CICLOALCOILOXI O CICLOALCENILOXI, Y R{SUB,5} REPRESENTA UN RADICAL ALCOXI, ALCENILOXI, ALCINILOXI, EVENTUALMENTE SUSTITUIDO, O UN RADICAL CICLOALCOILOXI O CICLOALCENILOXI. LOS NUEVOS PRODUCTOS DE FORMULA GENERAL (I) EN LA QUE Z REPRESENTA UN RADICAL DE FORMULA GENERAL (II) PRESENTAN PROPIEDADES ANTITUMORALES Y ANTILEUCEMICAS NOTABLES.
ES96909193T 1995-03-27 1996-03-25 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen. Expired - Lifetime ES2140075T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503545A FR2732340B1 (fr) 1995-03-27 1995-03-27 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR9515381A FR2742754B1 (fr) 1995-12-22 1995-12-22 Procede de preparation de taxoides

Publications (1)

Publication Number Publication Date
ES2140075T3 true ES2140075T3 (es) 2000-02-16

Family

ID=26231838

Family Applications (2)

Application Number Title Priority Date Filing Date
ES96909192T Expired - Lifetime ES2143187T3 (es) 1995-03-27 1996-03-25 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES96909193T Expired - Lifetime ES2140075T3 (es) 1995-03-27 1996-03-25 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES96909192T Expired - Lifetime ES2143187T3 (es) 1995-03-27 1996-03-25 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.

Country Status (41)

Country Link
US (3) US5889043A (es)
EP (2) EP0817780B1 (es)
JP (2) JP2941951B2 (es)
KR (2) KR100485309B1 (es)
CN (2) CN1213042C (es)
AP (2) AP785A (es)
AR (1) AR001440A1 (es)
AT (2) ATE188471T1 (es)
AU (2) AU711227B2 (es)
BG (2) BG63009B1 (es)
BR (2) BR9607930A (es)
CA (2) CA2214321C (es)
CO (1) CO4700576A1 (es)
CZ (2) CZ287468B6 (es)
DE (2) DE69606028T2 (es)
DK (2) DK0817779T3 (es)
DZ (1) DZ2009A1 (es)
EA (2) EA000567B1 (es)
EE (2) EE03609B1 (es)
ES (2) ES2143187T3 (es)
GE (2) GEP20002188B (es)
GR (2) GR3031526T3 (es)
HU (2) HU223666B1 (es)
IL (1) IL117636A (es)
IS (2) IS2058B (es)
MA (1) MA23823A1 (es)
MY (1) MY121225A (es)
NO (2) NO316607B1 (es)
NZ (2) NZ304901A (es)
OA (2) OA10513A (es)
PE (1) PE51097A1 (es)
PL (2) PL188284B1 (es)
PT (1) PT817779E (es)
RO (2) RO115878B1 (es)
SK (2) SK281928B6 (es)
TN (1) TNSN96043A1 (es)
TR (2) TR199701040T1 (es)
TW (1) TW394765B (es)
UY (2) UY24192A1 (es)
WO (2) WO1996030356A1 (es)
ZA (1) ZA962399B (es)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
FR2771092B1 (fr) * 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
EP0982028A1 (en) * 1998-08-20 2000-03-01 Aventis Pharma S.A. New use of taxoid derivatives
SK2352001A3 (en) * 1998-08-20 2001-07-10 Aventis Pharma Sa New use of taxoid derivatives
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
KR20020002488A (ko) * 2000-02-02 2002-01-09 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서 ｃ10 헤테로치환된 아세테이트 탁산
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
AU2001290636A1 (en) * 2000-09-22 2002-04-02 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
EP1318794A2 (en) * 2000-09-22 2003-06-18 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
US6593334B1 (en) 2002-05-02 2003-07-15 The University Of North Carolina At Chapel Hill Camptothecin-taxoid conjugates as antimitotic and antitumor agents
ES2666694T3 (es) 2002-09-06 2018-05-07 Cerulean Pharma Inc. Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
US20040122081A1 (en) * 2002-11-08 2004-06-24 Gogate Uday Shankar Pharmaceutical compositions and methods of using taxane derivatives
CA2526278A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
GT200500025A (es) * 2004-02-13 2005-09-30 Taxanos sustituidos con esteres de ciclopentilo en c10
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
PE20061090A1 (es) * 2005-02-14 2006-10-12 Univ Florida State Res Found Preparaciones de taxanos sustituidos con esteres de ciclopropilo en c10
EP2428510A3 (en) * 2005-03-31 2012-06-13 Accord Healthcare Inc. Preparation of taxanes from 9-dihydro-13-acetylbaccatin III
EP2647641A1 (en) * 2005-11-04 2013-10-09 Accord Healthcare Inc. New methods for the preparation of taxanes using chiral auxiliaries
US7847111B2 (en) * 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
WO2008067403A2 (en) * 2006-11-28 2008-06-05 Encore Health Llc Presbyopia treatment by lens alteration
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
US20100197944A1 (en) * 2007-07-04 2010-08-05 Dr. Reddy's Laboratories Limited Docetaxel process and polymorphs
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
JP2011517455A (ja) 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン
AU2009282413B2 (en) 2008-08-11 2014-07-17 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr) 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
EP2493466B1 (en) 2009-10-29 2021-03-10 Sanofi Mature IP Novel antitumoral use of cabazitaxel
CN104208716A (zh) * 2009-11-23 2014-12-17 天蓝制药公司 用于传递治疗剂的基于环糊精的聚合物
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
CN102060815B (zh) * 2010-12-24 2012-09-26 重庆泰濠制药有限公司 一种紫杉烷类化合物的制备方法
EP2491925A1 (en) 2011-02-25 2012-08-29 Aventis Pharma S.A. Antitumoral combination comprising cabazitaxel and cisplatin
HUE046232T2 (hu) 2011-02-25 2020-02-28 Sanofi Mature Ip Kabazitaxelt és ciszplatint tartalmazó tumorellenes kombináció
EP2620148A1 (en) 2012-01-27 2013-07-31 Aventis Pharma S.A. Antitumoral combination comprising cabazitaxel and cisplatin
JP2014514306A (ja) * 2011-04-12 2014-06-19 プラス・ケミカルス・エスアー 固体形態のカバジタキセル及びその製造方法
MX2014001221A (es) 2011-08-02 2014-03-27 Astellas Pharma Inc Metodo para tratar el cancer mediante el uso combinado de farmacos.
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN104039771B (zh) * 2011-09-26 2017-10-27 Kabi费森尤斯肿瘤学有限公司 包括c(7)‑oh和c(13)‑oh甲硅烷基化或仅c(7)‑oh甲硅烷基化的用于制备卡巴他赛的方法
CN102336726B (zh) * 2011-09-30 2014-11-26 重庆泰濠制药有限公司 一种卡巴他赛的制备方法
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102603724B (zh) * 2011-10-20 2014-02-26 江苏红豆杉生物科技股份有限公司 二甲氧基紫杉烷类化合物纯化精制的方法
CN102424672A (zh) * 2011-10-20 2012-04-25 江苏红豆杉生物科技有限公司 脱保护基制备二甲氧基紫杉烷类化合物的方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
CN102417491B (zh) * 2011-10-31 2013-11-06 江苏红豆杉生物科技有限公司 以10-去乙酰基-巴卡丁iii为原料制备卡巴他赛的方法
US8722900B2 (en) * 2011-10-31 2014-05-13 Scinopharm Taiwan, Ltd. Process for cabazitaxel, and intermediates thereof
CN103874692A (zh) * 2011-11-01 2014-06-18 费森尤斯卡比肿瘤学有限公司 卡巴他赛的无定形形式和用于其制备的方法
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
CN102532064B (zh) * 2011-12-13 2015-06-17 重庆泰濠制药有限公司 二甲氧基多西他赛的合成方法
WO2013088335A1 (en) 2011-12-13 2013-06-20 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
WO2014022237A1 (en) * 2012-07-31 2014-02-06 Yung Shin Pharm. Ind. Co., Ltd. Amorphous cabazitaxel
CN102775435B (zh) * 2012-08-21 2015-04-08 江苏红豆杉生物科技股份有限公司 一种用于制备7,10-甲氧基多西他赛的中间体的合成方法
CN102775434B (zh) * 2012-08-21 2015-04-08 江苏红豆杉生物科技股份有限公司 一种7,10-二甲氧基紫杉烷化合物中间体的合成方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
KR101407353B1 (ko) * 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
CN104086514A (zh) * 2014-06-19 2014-10-08 上海应用技术学院 紫杉醇衍生物及其制备方法
JP6841772B2 (ja) 2015-02-17 2021-03-10 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム 前立腺癌の処置におけるカバジタキセルの使用
EP3093014A1 (en) * 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
CA3148115A1 (en) 2019-08-08 2021-02-11 Laekna Limited Method of treating cancer
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5739362A (en) 1991-09-23 1998-04-14 Florida State University Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US5489601A (en) 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5229526A (en) 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
MX9308012A (es) 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
AU695873B2 (en) 1993-12-21 1998-08-27 University Of Hawaii New cryptophycins
DE69504843T2 (de) 1994-06-28 1999-02-11 Upjohn Co 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
US6201140B1 (en) 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2745814B1 (fr) 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
NO973923D0 (no) 1997-08-26
CN1179776A (zh) 1998-04-22
MX9706568A (es) 1997-11-29
NO316379B1 (no) 2004-01-19
HUP9801201A2 (hu) 2000-05-28
IL117636A0 (en) 1996-07-23
AU5278196A (en) 1996-10-16
PL322499A1 (en) 1998-02-02
JPH11502531A (ja) 1999-03-02
KR19980703287A (ko) 1998-10-15
AP9701090A0 (en) 1997-10-31
AR001440A1 (es) 1997-10-22
CZ303097A3 (cs) 1998-01-14
TW394765B (en) 2000-06-21
EP0817779A1 (fr) 1998-01-14
CA2214319C (fr) 2004-02-17
NO973922L (no) 1997-08-26
RO115877B1 (ro) 2000-07-28
CO4700576A1 (es) 1998-12-29
EA000567B1 (ru) 1999-12-29
IL117636A (en) 2004-08-31
TR199701040T1 (xx) 1998-01-21
AU703278B2 (en) 1999-03-25
SK281928B6 (sk) 2001-09-11
AP9701093A0 (en) 1997-10-31
BG101917A (en) 1998-10-30
WO1996030356A1 (fr) 1996-10-03
PL188284B1 (pl) 2005-01-31
EE9700315A (et) 1998-06-15
ATE188471T1 (de) 2000-01-15
EA000709B1 (ru) 2000-02-28
OA10513A (fr) 2002-04-22
HUP9801204A3 (en) 2000-12-28
RO115878B1 (ro) 2000-07-28
OA10514A (fr) 2002-04-22
EE03608B1 (et) 2002-02-15
JPH11500141A (ja) 1999-01-06
NZ304901A (en) 1998-12-23
TR199701042T1 (xx) 1998-01-21
US5889043A (en) 1999-03-30
KR100485309B1 (ko) 2005-10-12
CZ287468B6 (en) 2000-12-13
CA2214321C (fr) 2008-01-22
GR3032316T3 (en) 2000-04-27
CA2214319A1 (fr) 1996-10-03
BR9607929A (pt) 1998-06-02
US6331635B1 (en) 2001-12-18
EA199700269A1 (ru) 1998-04-30
IS4567A (is) 1997-09-23
SK130197A3 (en) 1998-04-08
GR3031526T3 (en) 2000-01-31
ZA962399B (en) 1996-10-01
NO973923L (no) 1997-08-26
AU5278096A (en) 1996-10-16
EA199700270A1 (ru) 1998-02-26
KR19980703357A (ko) 1998-10-15
CZ303297A3 (cs) 1998-01-14
BR9607930A (pt) 1998-06-02
DK0817780T3 (da) 2000-03-27
DK0817779T3 (da) 2000-06-19
AP753A (en) 1999-07-21
DE69604653D1 (de) 1999-11-18
ATE185562T1 (de) 1999-10-15
IS4536A (is) 1997-07-31
EP0817780A1 (fr) 1998-01-14
HUP9801201A3 (en) 2000-12-28
NO316607B1 (no) 2004-03-08
PT817779E (pt) 2000-04-28
US6387946B1 (en) 2002-05-14
AP785A (en) 1999-11-26
TNSN96043A1 (fr) 2005-03-15
EE03609B1 (et) 2002-02-15
DE69606028D1 (de) 2000-02-10
DE69606028T2 (de) 2000-08-10
UY24192A1 (es) 1996-06-14
WO1996030355A1 (fr) 1996-10-03
NZ304900A (en) 1998-09-24
JP2941951B2 (ja) 1999-08-30
BG101918A (en) 1998-10-30
EP0817779B1 (fr) 2000-01-05
SK281927B6 (sk) 2001-09-11
IS2058B (is) 2005-10-14
PE51097A1 (es) 1997-12-22
DZ2009A1 (fr) 2002-10-23
BG63009B1 (bg) 2001-01-31
SK130297A3 (en) 1998-03-04
US20020038038A1 (en) 2002-03-28
HU223666B1 (hu) 2004-11-29
IS2056B (is) 2005-10-14
BG63121B1 (bg) 2001-04-30
CZ287326B6 (en) 2000-10-11
ES2143187T3 (es) 2000-05-01
EP0817780B1 (fr) 1999-10-13
EE9700323A (et) 1998-06-15
CA2214321A1 (fr) 1996-10-03
MY121225A (en) 2006-01-28
HU223732B1 (hu) 2004-12-28
PL322465A1 (en) 1998-02-02
CN1152870C (zh) 2004-06-09
JP3790826B2 (ja) 2006-06-28
KR100297196B1 (ko) 2001-11-22
CN1213042C (zh) 2005-08-03
DE69604653T2 (de) 2000-05-31
HUP9801204A1 (hu) 2000-05-28
GEP20002211B (en) 2000-08-25
AU711227B2 (en) 1999-10-07
NO973922D0 (no) 1997-08-26
UY24370A1 (es) 2001-10-25
GEP20002188B (en) 2000-07-25
MX9706278A (es) 1997-10-31
PL188987B1 (pl) 2005-05-31
MA23823A1 (fr) 1996-10-01
CN1179775A (zh) 1998-04-22

Similar Documents

Publication Publication Date Title
ES2143187T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2148758T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2101513T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
AR005197A1 (es) Derivados de taxoides, su preparacion y composiciones farmaceuticas que los contienen
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ES2055523T3 (es) Agentes antifungicos de triazol.
ES2179113T3 (es) Composiciones dentales economicas que contienen novedosos aluminosilicatos de sodio.
MY103233A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
FI840027A0 (fi) Disubstituerade prolinderivat, foerfaranden foer deras framstaellning och deras anvaendning
ES2151155T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2161446T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2054944T3 (es) Bis-(tri-t-alquilfenoxi) difosfaespiroundecanos.
ES2131864T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
FI101704B1 (fi) Menetelmä uusien, antiateroskleroottisina aineina käytettävien bis[4-(2,6-dialkyyli)fenoli]silaanijohdannaisten valmistamiseksi
ES2146275T3 (es) Derivados de camptotecina, preparaciones de los mismos y agentes antitumorales.
ES2112670T3 (es) Derivados de ciclodextrina y su utilizacion, particularmente en cosmetica.
ES2162126T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
FI904663A0 (fi) Nya substituerade alkylpiperidiner och deras anvaendning som inhibitorer i kolesterolsyntes.
DK299584A (da) Hidtil ukendte prostacyklinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
ES2057894T3 (es) Activadores para percompuestos inorganicos.
ES2059767T3 (es) Derivado de 1,4-dihidropiridina.
PE130099A1 (es) Nuevos derivados de la equinocandina, su procedimiento de preparacion y su aplicacion como fungicidas
ES2051876T3 (es) Procedimiento para preparar derivados de la 1-bencenosulfonil-2-oxo-5-alquiltio-pirrolidina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 817780

Country of ref document: ES